机构:[1]State Key Laboratory of Oncology in Southern China, Sun Yat-sen University Cancer Center Collaborative Innovation Center for Cancer Medicine, No. 651 Dongfeng East Road, Guangzhou 510060, China.[2]Medical Oncology, Sichuan Cancer Hospital and Institute, Second People’s Hospital of Sichuan Province, Chengdu 614000, PR China.四川省人民医院四川省肿瘤医院[3]Department of Colorectal and Anal Surgery, the Sixth Affiliated Hospital of Sun Yat-sen University, Guangzhou, PR China.中山大学附属第六医院[4]CAS Key Laboratory of Pathogenic Microbiology and Immunology, Institute of Microbiology, Chinese Academy of Sciences, Beijing, PR China.[5]Guangdong Provincial Key Laboratory of Tumor-targeted Drug and Guangzhou Enterprise Key Laboratory of Gene Medicine, Guangzhou Doublle Bioproducts Inc., Guangzhou, Guangdong, China.
Background: OTUB1 (OTU deubiquitinase, ubiquitin aldehyde binding 1) is a deubiquitinating enzyme (DUB) that belongs to the OTU (ovarian tumor) superfamily. The aim of this study was to clarify the role of OTUB1 in colorectal cancer (CRC) and to identify the mechanism underlying its function. Methods: Two hundred and sixty CRC samples were subjected to association analysis of OTUB1 expression and clinicopathological variables using immunohistochemical (IHC) staining. Overexpression of OTUB1 was achieved in SW480 and DLD-1 cells, and downregulation of OTUB1 was employed in SW620 cells. Then, migration and invasion assays were performed, and markers of the epithelial-mesenchymal transition (EMT) were analyzed. In addition, hepatic metastasis models in mice were used to validate the function of OTUB1 in vivo. Results: OTUB1 was overexpressed in CRC tissues, and the expression level of OTUB1 was associated with metastasis. A high expression level of OTUB1 was also associated with poor survival, and OTUB1 served as an independent prognostic factor in multivariate analysis. OTUB1 also promoted the metastasis of CRC cell lines in vitro and in vivo by regulating EMT. Conclusions: OTUB1 promotes CRC metastasis by facilitating EMT and acts as a potential distant metastasis marker and prognostic factor in CRC. Targeting OTUB1 may be helpful for the treatment of CRC.
基金:
National High Technology Research and Development Program of China (863 Program)National High Technology Research and Development Program of China [2012AA02A204]; National Natural Science Foundation of China [81472256, 81472252, 81272638]; National Basic Research Program of China (973 Program)National Basic Research Program of China [2010CB912201, 2011CB504805]; National Major Scientific and Technological Special Project [2012ZX09401015]; Health & Medical Collaborative Innovation Project of Guangzhou City, China [201400000001]; Guangdong Innovative Research Team Program [2009010058]; Guangdong Provincial Science and Technology Projects [2011A080502010]
第一作者机构:[1]State Key Laboratory of Oncology in Southern China, Sun Yat-sen University Cancer Center Collaborative Innovation Center for Cancer Medicine, No. 651 Dongfeng East Road, Guangzhou 510060, China.
通讯作者:
通讯机构:[1]State Key Laboratory of Oncology in Southern China, Sun Yat-sen University Cancer Center Collaborative Innovation Center for Cancer Medicine, No. 651 Dongfeng East Road, Guangzhou 510060, China.[4]CAS Key Laboratory of Pathogenic Microbiology and Immunology, Institute of Microbiology, Chinese Academy of Sciences, Beijing, PR China.[5]Guangdong Provincial Key Laboratory of Tumor-targeted Drug and Guangzhou Enterprise Key Laboratory of Gene Medicine, Guangzhou Doublle Bioproducts Inc., Guangzhou, Guangdong, China.
推荐引用方式(GB/T 7714):
Yi Zhou,Jiangxue Wu,Xiang Fu,et al.OTUB1 promotes metastasis and serves as a marker of poor prognosis in colorectal cancer[J].MOLECULAR CANCER.2014,13:doi:10.1186/1476-4598-13-258.
APA:
Yi Zhou,Jiangxue Wu,Xiang Fu,Wuying Du,Ling Zhou...&Wenlin Huang.(2014).OTUB1 promotes metastasis and serves as a marker of poor prognosis in colorectal cancer.MOLECULAR CANCER,13,
MLA:
Yi Zhou,et al."OTUB1 promotes metastasis and serves as a marker of poor prognosis in colorectal cancer".MOLECULAR CANCER 13.(2014)